open access | register
Medical Conferences

Medical Conferences

  • Conference Reports
  • Conference Proceedings
  • Specialties
    • Cardiology
    • Dermatology
    • Endocrinology
    • Gastroenterology
    • Haematology
    • Nephrology
    • Neurology
    • Oncology
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Urology
  • Multimedia
    • Podcast channel
    • Video channel
  • About
    • 2025 Medicom Conference Planning
    • About Conference Proceedings
    • Webinar
Home > Cardiology > AHA 2023

AHA 2023


American Heart Association
11–13 November 2023
Philadelphia, PA, USA
  • Table of Contents
  • Colophon

Table of Contents



Featured articles

Letter from the Editor

Editor
Prof. Marc Bonaca, University of Colorado, USA

Abelacimab substantially lowers bleeding risk compared with rivaroxaban 

Presented By
Dr Christian Ruff, Brigham and Women’s Hospital, USA

AHA 2023 Highlights Podcast

Presented By
Robert van den Heuvel, Medicom

Hot Topics in CAD/PAD

MINT: Liberal or restrictive transfusion strategy in MI with anaemia? 

Presented By
Dr Jeffrey Carson, Rutgers University, NJ, USA

ORBITA-2 confirms PCI effective for symptom relief in patients with stable angina 

Presented By
Dr Christopher Rajkumar, Imperial College London, UK

Nicotinamide riboside shows promising trend for walking function in PAD 

Presented By
Prof. Mary McDermott, Northwestern University, USA

Pemafibrate reduces microvascular complications of PAD and T2D 

Presented By
Dr Aruna Pradhan, Brigham and Women’s Hospital, USA

Dapagliflozin improves cardiometabolic outcomes in myocardial infarction  

Presented By
Prof. Stefan James, Uppsala University, Sweden

Optimising Hypertension Outcomes

Edoxaban versus warfarin in chronic thromboembolic pulmonary hypertension

Presented By
Dr Kazuya Hosokawa, Kyushu University, Japan

Sodium intake and blood pressure: new insights

Presented By
Dr Deepak Gupta, Vanderbilt University Medical Centre, USA

Intensive BP intervention reduces risk of dementia 

Presented By
Dr Jiang He, Tulane University, USA

Post-partum intervention lowers BP after hypertensive pregnancy 

Presented By
Dr Jamie Kitt, University of Oxford, UK

Biannual zilebesiran associated with substantial BP reductions 

Presented By
Prof. George Bakris, University of Chicago, USA

Future of Lipid-Lowering Therapies

Encouraging data for lepodisiran as Lp(a) lowering therapy 

Presented By
Dr Steven Nissen, Cleveland Clinic, USA

Gene editing may change the treatment landscape of hypercholesterolaemia 

Presented By
Dr Andrew Bellinger, Verve Therapeutics, USA

REPRIEVE: Mechanisms behind MACE reduction in HIV population on pitavastatin

Presented By
Dr Michael Lu, Massachusetts General Hospital, USA

Recaticimab may offer a solution for uncontrolled hypercholesterolaemia

Presented By
Dr Xin Du, Beijing Anzhen Hospital, China

Atrial Fibrillation and Sudden Cardiac Death

Abelacimab substantially lowers bleeding risk compared with rivaroxaban 

Presented By
Dr Christian Ruff, Brigham and Women’s Hospital, USA

Liraglutide may improve post-ablation outcomes in obese patients with AF

Presented By
Dr Jeffrey Goldberger, University of Miami, USA

Single or dual cardioversion in patients with obesity and AF?

Presented By
Dr Joshua Aymond, Ochsner Health, USA

NOAH-AFNET 6: Does the duration of AHRE influence response to edoxaban?

Presented By
Dr Nina Becher, University of Hamburg, Germany

ARTESIA: How useful is anticoagulation in subclinical AF? 

Presented By
Prof. Jeff Healey, McMaster University, Canada

Jewel IDE: High compliance rates for novel patch wearable cardioverter defibrillator

Presented By
Dr John Hummel, Ohio State University, USA

Sudden cardiac death in athletes: incidence, causes, and trends over 20 years

Presented By
Dr Bradley Petek, Oregon Health and Science University, USA

Miscellaneous Trials

Successful results for semaglutide in the highly anticipated SELECT trial 

Presented By
Dr Michael Lincoff, Cleveland Clinic, USA

Can a walking intervention improve functional status and quality of life in HFrEF?

Presented By
Dr Tomas Vetrovsky, Charles University, Czechia

Head-to-head: Surgical embolectomy versus ultrasound-assisted thrombolysis in high-risk pulmonary embolism

Presented By
Dr Stefan Stortecky, University of Bern, Switzerland
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com